Top compounds associated with response to ZFP14


Feature Type Standardized
Nominal ANOVA
mRNA barasertib CTRPv2 pan-cancer AAC 0.2 1e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.21 3e-09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA pac-1 CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA ABT-199 CTRPv2 pan-cancer AAC 0.23 2e-07
mRNA prima-1 CTRPv2 pan-cancer AAC 0.17 2e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.16 2e-07
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA decitabine CTRPv2 pan-cancer AAC 0.14 6e-07
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.16 6e-07
Download CSV